Scheduled Maintenance Notice

Please note that Researcher Profiles will be undergoing scheduled maintenance on Wednesday 7th Oct, from 8:00am to 9:00am. During this time, the Researcher Profiles system will be unavailable. We apologise for any inconvenience and appreciate your understanding.

Select Publications

Journal articles

Macia L; Tsai VW-W; Nguyen AD; Johnen H; Kuffner T; Shi Y-C; Lin S; Herzog H; Brown DA; Breit SN; Sainsbury A, 2012, 'Macrophage inhibitory cytokine 1 (MIC-1/GDF15) decreases food intake, body weight and improves glucose tolerance in mice on normal & obesogenic diets.', PLoS One, 7, pp. e34868, http://dx.doi.org/10.1371/journal.pone.0034868

Doyle KL; Hort YJ; Herzog H; Shine J, 2012, 'Neuropeptide Y and peptide YY have distinct roles in adult mouse olfactory neurogenesis', Journal of Neuroscience Research, 90, pp. 1126 - 1135, http://dx.doi.org/10.1002/jnr.23008

Tasan RO; Verma D; Mietzsch M; Heilbronn R; Herzog H; Sperk G, 2012, 'Neuropeptide Y modulates fear and fear extinction in distinct nuclei of the amygdala', BMC Pharmacology and Toxicology, 13, http://dx.doi.org/10.1186/2050-6511-13-s1-a87

Macia L; Yulyaningsih E; Pangon L; Nguyen AD; Lin S; Shi YC; Zhang L; Bijker M; Grey S; Mackay F; Herzog H; Sainsbury A, 2012, 'Neuropeptide Y1 receptor in immune cells regulates inflammation and insulin resistance associated with diet-induced obesity.', Diabetes, 61, pp. 3228 - 3238, http://dx.doi.org/10.2337/db12-0156

Decressac M; Pain S; Chabeauti P; Frangeul L; Thiriet N; Herzog H; Vergote J; Chalon S; Jaber M; Gaillard A, 2012, 'Neuroprotection by neuropeptide Y in cell and animal models of Parkinson's disease', Neurobiology of Aging, 33, pp. 2125 - 2137, http://www.ncbi.nlm.nih.gov/pubmed/21816512

Verma D; Tasan RO; Herzog H; Sperk G, 2012, 'NPY controls fear conditioning and fear extinction by combined action on Y 1 and Y 2 receptors', British Journal of Pharmacology, 166, pp. 1461 - 1473, http://dx.doi.org/10.1111/j.1476-5381.2012.01872.x

Zhang L; Nguyen AD; Lee I-CJ; Yulyaningsih E; Riepler SJ; Stehrer B; Enriquez RF; Lin S; Shi Y-C; Baldock PA; Sainsbury A; Herzog H, 2012, 'NPY modulates PYY function in the regulation of energy balance and glucose homeostasis.', Diabetes Obes Metab, 14, pp. 727 - 736, http://dx.doi.org/10.1111/j.1463-1326.2012.01592.x

Pjetri E; Adan RAH; Herzog H; De haas R; Oppelaar H; Spierenburg HA; Olivier B; Kas M, 2012, 'NPY receptor subtype specification for behavioral adaptive strategies during limited food access', Genes Brain and Behavior, 11, pp. 105 - 112, http://dx.doi.org/10.1111/j.1601-183X.2011.00732.x

Herzog H, 2012, 'NPY: Beyond the regulation of energy metabolism', Obesity Research & Clinical Practice, 6, pp. 2 - 3, http://dx.doi.org/10.1016/j.orcp.2012.08.005

Jain P; Hassan A; Herzog H; Holzer P, 2012, 'Peptide YY and neuropeptide Y in regulation of pain and spatial learning and memory', BMC Pharmacology and Toxicology, 13, http://dx.doi.org/10.1186/2050-6511-13-s1-a58

Schmid E; Nogalo M; Bechrakis NE; Fischer-colbrie R; Tasan RO; Sperk G; Theurl M; Beer AGE; Kirchmair R; Herzog H; Troger J, 2012, 'Secretoneurin, substance P and neuropeptide Y in the oxygen-induced retinopathy in C57Bl/6N mice', Peptides, 37, pp. 252 - 257, http://dx.doi.org/10.1016/j.peptides.2012.07.024

Zhang L; Yagi M; Herzog H, 2012, 'The role of NPY and Ghrelin in anorexia nervosa', Current Pharmaceutical Design, 18, pp. 4766 - 4778, http://www.ncbi.nlm.nih.gov/pubmed/22632858

Tough IR; Forbes S; Tolhurst RS; Ellis M; Herzog H; Bornstein JC; Cox HM, 2011, 'Endogenous peptide YY and neuropeptide y inhibit colonic ion transport, contractility and transit differentially via Y1 and Y2 receptors', British Journal of Pharmacology, 164, pp. 471 - 484, http://dx.doi.org/10.1111/j.1476-5381.2011.01401.x

Nguyen AD; Lin S; Herzog H; Sainsbury A, 2011, 'Hypothalamus-specific deletion of Y1 and Y5 receptors EXACERBATES high fat diet-induced obesity', Obesity Research & Clinical Practice, 5, pp. 41 - 41, http://dx.doi.org/10.1016/j.orcp.2011.08.134

Purtell L; Sze L; Loughnan GT; Smith EM; Herzog H; Sainsbury-Salis A; Steinbeck KS; Campbell LV; Viardot A, 2011, 'In adults with Prader-Willi syndrome, elevated ghrelin levels are more consistent with hyperphagia than high PYY and GLP-1 levels', Neuropeptides, 45, pp. 301 - 307, http://dx.doi.org/10.1016/j.npep.2011.06.001

Schunk E; Aigner C; Stefanova N; Wenning G; Herzog H; Schwarzer C, 2011, 'Kappa opioid receptor activation blocks progressive neurodegeneration after kainic acid injection', Hippocampus, 21, pp. 1010 - 1020, http://dx.doi.org/10.1002/hipo.20813

La Sala MS; Hurtado DM; Acosta A; Zolotukhin S; Herzog H; Dotson CD, 2011, 'Modulation of taste sensitivity and feeding by oral PYY signaling', Appetite, 57, pp. s24, http://dx.doi.org/10.1016/j.appet.2011.05.204

Nguyen AD; Herzog H; Sainsbury A, 2011, 'Neuropeptide Y and peptide YY: important regulators of energy metabolism.', Curr Opin Endocrinol Diabetes Obes, 18, pp. 56 - 60, http://dx.doi.org/10.1097/MED.0b013e3283422f0a

Tasan RO; Verma D; Mietzsch M; Weger S; Heilbronn R; Herzog H; Sperk G, 2011, 'Neuropeptide Y Y2 receptors modulate trace fear conditioning and spatial memory in the dorsal hippocampus', BMC Pharmacology, 11, pp. a2, http://dx.doi.org/10.1186/1471-2210-11-s2-a2

Yulyaningsih E; Zhang L; Herzog H; Sainsbury-Salis A, 2011, 'NPY receptors as potential targets for anti-obesity drug development', British Journal of Pharmacology, 163, pp. 1170 - 1202, http://dx.doi.org/10.1111/j.1476-5381.2011.01363.x

Verma D; Tasan RO; Mietzsch M; Weger S; Heilbronn R; Herzog H; Sperk G, 2011, 'Reduced fear conditioning after viral vector mediated neuropeptide Y administration into the basolateral amygdala', BMC Pharmacology, 11, http://dx.doi.org/10.1186/1471-2210-11-s2-a3

Zhang X; Herzog H; Song J; Wang XL; Fan C; Guo H, 2011, 'Response properties of the electrosensory neurons in hindbrain of the white sturgeon, Acipenser transmontanus', Neurosci Bull, 27, pp. 422 - 429

Acosta AC; Hurtado MD; Gorbatyuk OS; Duncan D; Aslanidi GV; Campbell-thompson ML; Zhang L; Herzog H; Voutetakis A; Baum BJ; Zolotukhin S, 2011, 'Salivary PYY: A putative bypass to satiety', PLoS One, 5, pp. Article no. e26137, http://dx.doi.org/10.1371/journal.pone.0026137

Painsipp E; Herzog H; Sperk G; Holzer P, 2011, 'Sex-dependent control of murine emotional-affective behaviour in health and colitis by peptide YY and neuropeptide y', British Journal of Pharmacology, 163, pp. 1302 - 1314, http://dx.doi.org/10.1111/j.1476-5381.2011.01326.x

Zhang L; Bijker MS; Herzog H, 2011, 'The neuropeptide y system: Pathophysiological and therapeutic implications in obesity and cancer', Pharmacology and Therapeutics, 131, pp. 91 - 113, http://dx.doi.org/10.1016/j.pharmthera.2011.03.011

Macia L; Rao PT; Wheway J; Sierro F; Mackay F; Herzog H, 2011, 'Y1 signalling has a critical role in allergic airway inflammation', Immunology and Cell Biology, 89, pp. 882 - 888, http://dx.doi.org/10.1038/icb.2011.6

Mountford J; Zhang L; Herzog H; Thompson P, 2010, 'Synthesis of Neuropeptide Y analogues as PET imaging agents', JOURNAL OF PEPTIDE SCIENCE, 16, pp. 89 - 89, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000281610800213&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Shi Y-C; Lin S; Wong IPL; Baldock PA; Aljanova A; Enriquez RF; Castillo L; Mitchell NF; Ye J-M; Zhang L; Macia L; Yulyaningsih E; Nguyen AD; Riepler SJ; Herzog H; Sainsbury A, 2010, 'NPY neuron-specific Y2 receptors regulate adipose tissue and trabecular bone but not cortical bone homeostasis in mice.', PLoS One, 5, pp. e11361, http://dx.doi.org/10.1371/journal.pone.0011361

Cox HM; Tough IR; Woolston A-M; Zhang L; Nguyen AD; Sainsbury A; Herzog H, 2010, 'Peptide YY is critical for acylethanolamine receptor Gpr119-induced activation of gastrointestinal mucosal responses.', Cell Metab, 11, pp. 532 - 542, http://dx.doi.org/10.1016/j.cmet.2010.04.014

Karl T; Chesworth R; Duffy L; Herzog H, 2010, 'Acoustic startle response and sensorimotor gating in a genetic mouse model for the NPY Y1 receptor.', Neuropeptides, 44, pp. 233 - 239

Zhang L; Lee NJ; Nguyen AD; Enriquez RF; Riepler SJ; Stehrer B; Yulyaningsih E; Lin S; Shi YC; Baldock PA; Herzog H; Sainsbury A, 2010, 'Additive actions of the cannabinoid and neuropeptide Y systems on adiposity and lipid oxidation.', Diabetes Obes Metab, 12, pp. 591 - 603, http://dx.doi.org/10.1111/j.1463-1326.2009.01193.x

Lin ED; Lin S; Aljanova A; During M; Herzog H, 2010, 'Adult-onset hippocampal-specific neuropeptide Y overexpression confers mild anxiolytic effect in mice', European Neuropsychopharmacology, 20, pp. 164 - 175

Purtell L; Sze L; Loughnan G; Smith E; Herzog H; Sainsbury A; Steinbeck K; Campbell LV; Viardot A, 2010, 'Critical role for ghrelin, but not PYY or GLP-1, in Prader–Willi syndrome hyperphagia', Obesity Research & Clinical Practice, 4, pp. S6 - S6, http://dx.doi.org/10.1016/j.orcp.2010.09.013

Painsipp E; Sperk G; Herzog H; Holzer P, 2010, 'Delayed stress-induced differences in locomotor and depression-related behaviour in female neuropeptide-Y Y1 receptor knockout mice', Journal of Psychopharmacology, 24, pp. 1541-9, http://dx.doi.org/10.1177/0269881109104851

Schwarzer C; Lutsch C; Schunk E; Kastenberger I; Herzog H, 2010, 'Endogenous dynorphin in emotional control and stress response revisited', BMC Pharmacology, 10, http://dx.doi.org/10.1186/1471-2210-10-s1-a32

Painsipp E; Herzog H; Holzer P, 2010, 'Evidence from knockout mice that neuropeptide-Y Y2 and Y4 receptor signalling prevents long-term depression-like behaviour caused by immune challenge', Journal of Psychopharmacology, 24, pp. 1551 - 1560

Wong IP; Baldock PA; Herzog H, 2010, 'Gastrointestinal peptides and bone health.', Curr Opin Endocrinol Diabetes Obes, 17, pp. 44 - 50, http://dx.doi.org/10.1097/MED.0b013e3283344a05

Yulyaningsih E; Macia L; Driesler F; Herzog H; Sainsbury A, 2010, 'Lack of Y6 receptor signaling in mice results in a lean phenotype on a chow diet but exacerbated high fat diet-induced obesity', Obesity Research & Clinical Practice, 4, pp. S65 - S65, http://dx.doi.org/10.1016/j.orcp.2010.09.127

Prior LJ; Purtell L; Duke S; Campbell L; Sainsbury A; Herzog H, 2010, 'Mouse model of Prader–Willi syndrome: The role of SNORD116 in the regulation of energy homeostasis', Obesity Research & Clinical Practice, 4, pp. S6 - S6, http://dx.doi.org/10.1016/j.orcp.2010.09.012

Zengin A; Zhang L; Herzog H; Baldock PA; Sainsbury A, 2010, 'Neuropeptide Y and sex hormone interactions in humoral and neuronal regulation of bone and fat.', Trends Endocrinol Metab, 21, pp. 411 - 418, http://dx.doi.org/10.1016/j.tem.2010.02.004

Tasan RO; Verma D; Herzog H; Sperk G, 2010, 'Neuropeptide Y in the basolateral amygdala modulates the acquisition of conditioned fear', BMC Pharmacology, 10, http://dx.doi.org/10.1186/1471-2210-10-s1-a33

Zhang L; Macia L; Turner N; Enriquez RF; Riepler SJ; Nguyen AD; Lin S; Lee NJ; Shi YC; Yulyaningsih E; Slack K; Baldock PA; Herzog H; Sainsbury A, 2010, 'Peripheral neuropeptide Y Y1 receptors regulate lipid oxidation and fat accretion.', Int J Obes (Lond), 34, pp. 357 - 373, http://dx.doi.org/10.1038/ijo.2009.232

Viardot AC; Sze L; Purtell L; Sainsbury-Salis A; Loughnan G; Smith E; Herzog H; Steinbeck K; Campbell LV, 2010, 'Prader-willi syndrome is associated with activation of the innate immune system independently of central adiposity and insulin resistance', Journal of Clinical Endocrinology and Metabolism, 95, pp. 3392 - 3399

Karl T; Chesworth R; Duffy L; Herzog H, 2010, 'Schizophrenia-relevant behaviours in a genetic mouse model for Y2 deficiency', Behavioural Brain Research, 207, pp. 434 - 440

Tasan R; Nguyen NK; Weger S; Sartori S; Singewald N; Heilbronn R; Herzog H; Sperk G, 2010, 'The central and basolateral amygdala are critical sites of neuropeptide Y/Y2 receptor-mediated regulation of anxiety and depression', Journal of Neuroscience, 30, pp. 6282 - 6290

Sainsbury A; Shi Y-C; Zhang L; Aljanova A; Lin Z; Nguyen AD; Herzog H; Lin S, 2010, 'Y4 receptors and pancreatic polypeptide regulate food intake via hypothalamic orexin and brain-derived neurotropic factor dependent pathways.', Neuropeptides, 44, pp. 261 - 268, http://dx.doi.org/10.1016/j.npep.2010.01.001

Lin S; Shi Y-C; Yulyaningsih E; Aljanova A; Zhang L; Macia L; Nguyen AD; Lin E-JD; During MJ; Herzog H; Sainsbury A, 2009, 'Critical role of arcuate Y4 receptors and the melanocortin system in pancreatic polypeptide-induced reduction in food intake in mice.', PLoS One, 4, pp. e8488, http://dx.doi.org/10.1371/journal.pone.0008488

Baldock PA; Lee NJ; Driessler F; Lin S; Allison S; Stehrer B; Lin E-JD; Zhang L; Enriquez RF; Wong IPL; McDonald MM; During M; Pierroz DD; Slack K; Shi YC; Yulyaningsih E; Aljanova A; Little DG; Ferrari SL; Sainsbury A; Eisman JA; Herzog H, 2009, 'Neuropeptide Y knockout mice reveal a central role of NPY in the coordination of bone mass to body weight.', PLoS One, 4, pp. e8415, http://dx.doi.org/10.1371/journal.pone.0008415

Allison SJ; Baldock PA; Enriquez R; Lin E; During M; Gardiner EM; Eisman JA; Sainsbury A; Herzog H, 2009, 'Critical interplay between neuropeptide Y and sex steroid pathways in bone and adipose tissue homeostasis', Journal of Bone and Mineral Research, 24, pp. 294 - 304

Nguyen NK; Sartori S; Herzog H; Tasan R; Sperk G; Singewald N, 2009, 'Effect of neuropeptide Y Y2 receptor deletion on emotional stress-induced neuronal activation in mice', Synapse, 63, pp. 236 - 246


Back to profile page